G1 Therapeutics to Host Webcast and Conference Call for First Quarter 2024 Update

G1 Therapeutics, a leading oncology company, is set to host a webcast and conference call to provide a financial and corporate update for the first quarter of 2024. The event is scheduled for Wednesday, May 1, 2024, at 8:30 a.m. ET.

To participate in the event, interested individuals can register online to receive a dial-in number and unique PIN for access to the live conference call. While not mandatory, it is recommended to join 10 minutes prior to the start of the event. A live and archived webcast will also be available on the Events & Presentations page of the company’s website.

G1 Therapeutics is known for its commitment to developing next-generation therapies to improve the lives of cancer patients. The company’s first commercial product, COSELA® (trilaciclib), is already making a difference in the field of oncology. Additionally, G1 Therapeutics is actively evaluating therapies in combination with cytotoxic and immunotherapy treatments for triple-negative breast cancer and extensive stage small cell lung cancer.

For more information about G1 Therapeutics and its innovative approach to cancer treatment, visit their website at www.g1therapeutics.com. You can also follow the company on social media platforms like X (formerly known as Twitter) and LinkedIn.

G1 Therapeutics is dedicated to providing groundbreaking advancements in cancer care, and the upcoming webcast and conference call will offer valuable insights into the company’s progress and future plans. Don’t miss this opportunity to learn more about the cutting-edge work being done at G1 Therapeutics.